A study conducted by Oregon State University in the United States found that two acids found in the cannabis sativa plant have the ability to help the virus that causes Covid-19 disease not penetrate human cells.
This ability helps block an important process that generates infection according to the researchers. This research has been published in the Journal of Natural Products and directly points out that cannabidiolic acid (CBDA) and cannabigerolic acid (CBGA) bind to the spike protein of SARS-CoV-2 and prevent the virus from spreading the infection in cells.
“They bind to spike proteins so that those proteins can’t bind to the ACE2 enzyme, which abounds in the outer membrane of endothelial cells in the lungs and other organs,” said Richard Van Breemen, a researcher at the Oregon State Center for Global Hemp Innovation.
This research was carried out with a technique based on mass spectrometry. By analyzing the extracts, the researchers saw that these cannabis compounds are effective in blocking the alpha and beta variant. More research in development could yield results in new variants.
“These compounds have the potential to prevent and treat SARS-CoV-2 infection. CBDA and CBGA are produced by the cannabis plant as precursors to CBD and CBG, which are familiar to many consumers. However, they are different from acids and are not contained in hemp products,” Van Breemen said.
In addition, he said that although new variants resistant to cannabinoids may emerge, the combination between vaccines and these treatments could make it more difficult for the disease to enter the body.
Read the study: https://bit.ly/3FroU37
in Costa Rica. 
